Envestnet Asset Management Inc. Grows Position in Corteva, Inc. $CTVA

Envestnet Asset Management Inc. lifted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 5.9% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 2,138,576 shares of the company’s stock after purchasing an additional 119,759 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Corteva were worth $144,640,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in CTVA. Chilton Capital Management LLC increased its holdings in Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock worth $30,119,000 after acquiring an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC purchased a new position in Corteva during the third quarter valued at $4,284,000. New York State Teachers Retirement System grew its position in shares of Corteva by 4.5% in the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock valued at $37,290,000 after purchasing an additional 23,548 shares during the period. Truist Financial Corp increased its stake in shares of Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock worth $21,771,000 after purchasing an additional 13,910 shares in the last quarter. Finally, Nordea Investment Management AB raised its position in shares of Corteva by 27.4% during the 3rd quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock worth $5,103,000 after purchasing an additional 16,261 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raise Wolfe Research raise RBC raise
• Positive Sentiment: Brokerage consensus remains constructive (consensus “Moderate Buy”), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy
• Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role
• Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysis Conflicting analyst views
• Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution
• Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue miss After‑hours fall
• Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade
• Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact

Analyst Ratings Changes

Several equities research analysts recently issued reports on CTVA shares. Wolfe Research lifted their price objective on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday. Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a research report on Saturday. Rothschild & Co Redburn dropped their price target on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Citigroup increased their price objective on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Oppenheimer set a $86.00 target price on shares of Corteva in a research note on Thursday. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus target price of $82.37.

Corteva Stock Performance

NYSE CTVA opened at $72.63 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.07 and a current ratio of 1.43. The stock’s fifty day moving average is $68.82 and its two-hundred day moving average is $68.42. The firm has a market capitalization of $49.08 billion, a P/E ratio of 45.97, a price-to-earnings-growth ratio of 1.84 and a beta of 0.75. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $77.41.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period last year, the company earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.